Frequency News and Research

RSS

Research reveals that US children experience gastrointestinal issues

An increasing number of U.S. children are experiencing gastrointestinal issues that require interventions to resolve, according to research presented at Digestive Disease Week.

20 May 2013

Boston Scientific presents data on breakthrough products at Digestive Disease Week 2013

Boston Scientific Corporation is scheduled to participate in Digestive Disease Week 2013, May 18-21 in Orlando, Fla.

20 May 2013

Humans: The primary cause of global climate change

Do most scientists agree that human activity is causing global climate change? Yes, they do, according to an extensive analysis of the abstracts or summaries of scientific papers published over the past 20 years, even though public perception tends to be that climate scientists disagree over the fundamental cause of climate change.

17 May 2013

GE Healthcare introduces novel MR imaging technology

At an event held today at Hospital for Special Surgery, GE Healthcare introduced MAVRIC SL, a novel magnetic resonance imaging technique designed to address the growing clinical need to more accurately image soft tissue and bone in patients with MR Conditional-labeled implants, such as joint replacements and other instrumentation.

16 May 2013

Simponi injection gets FDA approval to treat adults with ulcerative colitis

The U.S. Food and Drug Administration today approved a new use for Simponi (golimumab) injection to treat adults with moderate to severe ulcerative colitis.

16 May 2013

Kinesia ProView™ launched to visualize motor symptom severity response to deep brain stimulation (DBS) in Parkinson’s patients

Great Lakes NeuroTechnologies announced today the product launch of Kinesia ProView™ to visualize motor symptom severity response during programming of deep brain stimulation (DBS) for Parkinson’s disease. Kinesia ProView provides a standardized platform to quantitatively assess how symptoms such as tremor, bradykinesia, and dyskinesias change in response to specific DBS settings during outpatient programming procedures.

15 May 2013

Study: Certain racial groups are more likely to suffer from effects of climate change

Some racial groups are more likely to bear the brunt of extreme heat waves because of where they live, according to a new study by researchers at the University of California, Berkeley.

15 May 2013

Medicaid opinions: Several state leaders come in for heat for not moving toward expansion

Editorials and columnists in several papers around the country pressed officials toward accepting a Medicaid expansion and offered suggestions about implementation. Also, comments continued about a recent study on Medicaid.

14 May 2013

Study examines key factors that influence development of mental disorder in Andalusia

Being a woman, unemployed and living in a situation of social adversity are the three strongest trigger influences in subjects with a genetic predisposition to mental disorder.

13 May 2013

More studies needed to determine how decision aids help guide choices for cancer screening

When it comes to a cancer diagnosis, timing can be everything - the sooner it's found, the more treatable it is. But when and how often should someone get screened?

13 May 2013

TYRX's AIGISRx Antibacterial Envelope reduces CIED infection rates by more than 90%

Use of TYRX, Inc.'s AIGISRx- Antibacterial Envelope reduced major infection rates by more than 90% in patients undergoing Cardiovascular Implantable Electronic Device replacement procedures compared to similar high-risk cohorts, according to the CITADEL & CENTURION clinical study results presented on Saturday at the Late Breaking Clinical Trials session at Heart Rhythm 2013, the Heart Rhythm Society's 34th Annual Scientific Sessions.

13 May 2013

Journal provides guidance for clinicians on prescribing exercise for depressed patients

Exercise has been shown to be an effective treatment for major depressive disorder, both when used alone and in combination with other treatments.

13 May 2013

Methylphenidate normalizes activation of several brain areas in children with ADHD

The stimulant drug methylphenidate "normalizes" activation of several brain areas in young patients with attention-deficit/hyperactivity disorder (ADHD), according to a review published in the May Harvard Review of Psychiatry. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.

10 May 2013

Uroplasty highlights results of STEP Study on PTNS treatments for overactive bladder

Uroplasty, Inc., a medical device company that develops, manufactures and markets innovative proprietary products for the treatment of voiding dysfunctions, today highlighted the 3-year results of the STEP Study on percutaneous tibial nerve stimulation treatments for overactive bladder using Uroplasty's Urgent PC Neuromodulation System.

10 May 2013

Study shows malaria transmission can be controlled by using bacteria

Mosquitoes are deadly efficient disease transmitters. Research conducted at Michigan State University, however, demonstrates that they also can be equally adept in curing diseases such as malaria.

10 May 2013

Drug resistant brain tumors: an interview with Prof. Mischel, Ludwig Institute for Cancer Research and Prof. Bensinger, University of California

In cancer, mutations in proteins that control cell growth are common, leading to unrestrained cellular proliferation and tumor formation.

9 May 2013

TRACK-HD study: A set of tests could help identify progression of Huntington's disease

Scientists have identified a set of tests that could help identify whether and how Huntington's disease is progressing in groups of people who are not yet showing symptoms.

9 May 2013

Phase 1b clinical study data of EBI-005 for treatment of dry eye disease presented at ARVO meeting

Eleven Biotherapeutics, a biopharmaceutical company designing and engineering novel and differentiated protein-based biotherapeutics for ocular diseases, announced today the presentation of data for EBI-005, the first IL-1 (Interleukin-1) signaling inhibitor designed for topical ocular administration, at the Association for Research in Vision and Ophthalmology 2013 Annual Meeting in Seattle, Washington.

9 May 2013

Aileron Therapeutics concludes first-in-human study of ALRN-5281 Stapled Peptide drug

Aileron Therapeutics, Inc. today announced the completion of the first-in-human study of its lead Stapled Peptide drug, ALRN-5281, a proprietary, long-acting growth-hormone-releasing hormone (GHRH) agonist for treating orphan endocrine disorders, including adult growth hormone (GH) deficiency and human immunodeficiency virus (HIV) lipodystrophy, as well as broader patient populations involving a wide variety of metabolic/endocrine diseases.

7 May 2013

New report highlights factors that contribute to asthma

There is still no cure for asthma, so for 22 million people in the U.S., this chronic disease continues to be a daily burden no matter where they live. But it's not just air pollution they should be worried about. Factors such as pollen, secondhand smoke – even high rates of poverty, a large uninsured population or a high number of ER visits – can be critical signs that certain cities and states are worse for families with asthma. It is especially true for people with severe asthma.

7 May 2013

Frequency News and Research

Research reveals that US children experience gastrointestinal issues

Boston Scientific presents data on breakthrough products at Digestive Disease Week 2013

Humans: The primary cause of global climate change

GE Healthcare introduces novel MR imaging technology

Simponi injection gets FDA approval to treat adults with ulcerative colitis

Kinesia ProView™ launched to visualize motor symptom severity response to deep brain stimulation (DBS) in Parkinson’s patients

Study: Certain racial groups are more likely to suffer from effects of climate change

Medicaid opinions: Several state leaders come in for heat for not moving toward expansion

Study examines key factors that influence development of mental disorder in Andalusia

More studies needed to determine how decision aids help guide choices for cancer screening

TYRX's AIGISRx Antibacterial Envelope reduces CIED infection rates by more than 90%

Journal provides guidance for clinicians on prescribing exercise for depressed patients

Methylphenidate normalizes activation of several brain areas in children with ADHD

Uroplasty highlights results of STEP Study on PTNS treatments for overactive bladder

Study shows malaria transmission can be controlled by using bacteria

Drug resistant brain tumors: an interview with Prof. Mischel, Ludwig Institute for Cancer Research and Prof. Bensinger, University of California

TRACK-HD study: A set of tests could help identify progression of Huntington's disease

Phase 1b clinical study data of EBI-005 for treatment of dry eye disease presented at ARVO meeting

Aileron Therapeutics concludes first-in-human study of ALRN-5281 Stapled Peptide drug

New report highlights factors that contribute to asthma

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News